Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2399-3642
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations ; volume:5 ; number:1 ; day:2 ; month:9 ; year:2022 ; pages:1-7 ; date:12.2022
Communications biology ; 5, Heft 1 (2.9.2022), 1-7, 12.2022
- Urheber
-
Trombetta, Claudia Maria
Piccini, Giulia
Pierleoni, Giulio
Leonardi, Margherita
Dapporto, Francesca
Marchi, Serena
Andreano, Emanuele
Paciello, Ida
Benincasa, Linda
Lovreglio, Piero
Buonvino, Nicola
Decaro, Nicola
Stufano, Angela
Lorusso, Eleonora
Bombardieri, Emilio
Ruello, Antonella
Viviani, Simonetta
Rappuoli, Rino
Molesti, Eleonora
Manenti, Alessandro
Montomoli, Emanuele
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s42003-022-03849-0
- URN
-
urn:nbn:de:101:1-2022112009292044335797
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Trombetta, Claudia Maria
- Piccini, Giulia
- Pierleoni, Giulio
- Leonardi, Margherita
- Dapporto, Francesca
- Marchi, Serena
- Andreano, Emanuele
- Paciello, Ida
- Benincasa, Linda
- Lovreglio, Piero
- Buonvino, Nicola
- Decaro, Nicola
- Stufano, Angela
- Lorusso, Eleonora
- Bombardieri, Emilio
- Ruello, Antonella
- Viviani, Simonetta
- Rappuoli, Rino
- Molesti, Eleonora
- Manenti, Alessandro
- Montomoli, Emanuele
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
Stimulation of homologous recombination in plants expressing heterologous recombinases
Homologous and heterologous expression of magnetosome operons from Magnetospirillum gryphiswaldense
Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
Vaccinations-Anstalt
Vaccinations-Atteste
Meningococcal Vaccinations
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
Stimulation of homologous recombination in plants expressing heterologous recombinases
Homologous and heterologous expression of magnetosome operons from Magnetospirillum gryphiswaldense
Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
Vaccinations-Anstalt
Vaccinations-Atteste
Meningococcal Vaccinations
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
Stimulation of homologous recombination in plants expressing heterologous recombinases
Homologous and heterologous expression of magnetosome operons from Magnetospirillum gryphiswaldense
Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
Vaccinations-Anstalt
Vaccinations-Atteste
Meningococcal Vaccinations
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster